Hospital
Columbia Medical Center of Lewisville Subsidiary LP
Columbia Medical Center of Lewisville Subsidiary LP was paid $6.91M by Medicaid between Oct 2020 and Dec 2024, across 54 billing codes. Its largest line is 99283, emergency room visit (moderate) — 55% of everything it billed.
33Billing provider infoCOLUMBIA MEDICAL CENTER OF LEWISVILLE SUBSIDIARY LP
LEWISVILLE, TX 75057
LEWISVILLE, TX 75057
33aNPI1255384533assigned 05/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.91M
24GClaims76,391
24DCodes billed54
24AFirst – last monthOct 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#23 of 109
Median peer was paid$1.15M
This provider vs. median6.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 997 | $94K | |
| 2021 | 19,601 | $1.38M | |
| 2022 | 24,503 | $2.13M | |
| 2023 | 20,795 | $2.30M | |
| 2024incomplete | 10,495 | $1.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 55% | 20,990 | 20,371 | $3.78M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 6,626 | 6,082 | $2.28M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.2% | 2,080 | 2,025 | $357K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 4,672 | 4,424 | $76K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,914 | 3,887 | $68K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,573 | 1,534 | $49K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,711 | 1,618 | $47K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,754 | 1,604 | $43K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,097 | 981 | $37K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 977 | 957 | $26K |
| 80053 | Comprehensive metabolic panel | <1% | 2,071 | 1,848 | $26K |
| 85027 | <1% | 6,669 | 5,933 | $21K |
42 more codes
| 87430 | <1% | 1,688 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,668 | $17K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,968 | $11K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 56 | $10K |
| 81001 | <1% | 3,376 | $8K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,284 | $6K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 375 | $4K |
| 93976 | <1% | 43 | $4K | |
| 87420 | <1% | 291 | $3K | |
| 83880 | <1% | 224 | $3K | |
| 83690 | <1% | 677 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 54 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 39 | $1K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 13 | $1K |
| 87070 | <1% | 203 | $1K | |
| 99285 | Emergency room visit (most serious) | <1% | 44 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 57 | $1K |
| 84484 | <1% | 661 | $1K | |
| 80061 | Lipid panel | <1% | 56 | $732.15 |
| 84703 | <1% | 158 | $674.74 | |
| 85730 | <1% | 197 | $593.97 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 129 | $589.42 |
| 85610 | <1% | 234 | $471.28 | |
| 82607 | <1% | 40 | $433.72 | |
| 82746 | <1% | 40 | $420.42 | |
| 84425 | <1% | 28 | $418.49 | |
| 84702 | <1% | 29 | $366.56 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 43 | $332.79 |
| 81025 | <1% | 57 | $265.88 | |
| 83540 | <1% | 40 | $247.98 | |
| 83550 | <1% | 28 | $203.58 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 42 | $181.11 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 78 | $157.87 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 31 | $109.22 |
| 80076 | <1% | 13 | $69.42 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 34 | $62.43 |
| 86900 | <1% | 28 | $60.24 | |
| 86901 | <1% | 28 | $60.24 | |
| 86677 | <1% | 15 | $47.79 | |
| 81003 | <1% | 12 | $13.23 | |
| A9270 | Non-covered item or service | 0% | 164 | $0.00 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOOTS, RHONDA (CFO)